Well if BMY doesn't have an interest in Oncosec for TNBC I am sure Merck will. Merck and Bristol Myers will continue to duke it out. On good PISCES data Merck will probably just buy them out and expand the Oncosec pipeline into many more indications to rival Bristol Myers. The future of Oncosec tech looks very compelling to any suitor in my opinion.
News 
Market Data 
Discover 
